InvestorsHub Logo
Post# of 252302
Next 10
Followers 833
Posts 119891
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 242071

Thursday, 07/21/2022 12:58:04 PM

Thursday, July 21, 2022 12:58:04 PM

Post# of 252302
(ENTA)—Shionogi’s COVID antiviral hits another setback:

https://www.bloomberg.com/news/articles/2022-07-20/shionogi-covid-pill-fails-to-win-japan-s-panel-backing

Shionogi & Co.’s experimental Covid-19 treatment Xocova failed to win the backing of health experts in Japan who said there wasn’t enough data to show the medicine’s efficacy.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.